Inspire Medical Systems sits in one of the most commercially mature segments of implantable neuromodulation, with hypoglossal nerve stimulation established as a regulated therapy for obstructive sleep apnea. Its positioning is strategically notable because it connects sleep medicine, surgical implantation, and closed-loop peripheral nerve stimulation in a narrowly defined clinical market.